Monday, August 15, 2022
name of Prensa Latina
Bandera inglesa
English Edition
name of Prensa Latina

NEWS

Asia | Ocean

New Delhi, Aug 15 (Prensa Latina) Bharat Biotech International Limited (BBIL) on Monday announced that its intra-nasal vaccine (BBV154) has proven to be safe, well-tolerated, and immunogenic in subjects in controlled clinical trials.